Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 702981, 8 pages
http://dx.doi.org/10.1155/2014/702981
Research Article

Caffeic Acid Phenethyl Ester Protects against Amphotericin B Induced Nephrotoxicity in Rat Model

1Department of Nephrology, School of Medicine, Internal Medicine, Süleyman Demirel University, East Campus, 32200 Isparta, Turkey
2Department of Medical Biology, School of Medicine, Mevlana University, 42030 Konya, Turkey
3Department of Dermatology, Isparta State Hospital, 32200 Isparta, Turkey
4Department of Biochemistry, School of Medicine, Süleyman Demirel University, 32200 Isparta, Turkey
5Department of Histology, School of Medicine, Süleyman Demirel University, 32200 Isparta, Turkey
6Department of Endocrinology and Metabolism, School of Medicine, Internal Medicine, Süleyman Demirel University, 32200 Isparta, Turkey

Received 28 February 2014; Accepted 31 May 2014; Published 16 June 2014

Academic Editor: Beatrice Charreau

Copyright © 2014 Atila Altuntaş et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Lemke, A. F. Kiderlen, and O. Kayser, “Amphotericin B,” Applied Microbiology and Biotechnology, vol. 68, no. 2, pp. 151–162, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Deray, “Amphotericin B nephrotoxicity,” Journal of Antimicrobial Chemotherapy, vol. 49, no. 1, pp. 37–41, 2002. View at Google Scholar · View at Scopus
  3. R. A. Branch, “Prevention of amphotericin B-induced renal impairment. A review on the use of sodium supplementation,” Archives of Internal Medicine, vol. 148, no. 11, pp. 2389–2394, 1988. View at Google Scholar · View at Scopus
  4. A. A. Hellebusch, F. Salama, and E. Eadie, “The use of mannitol to reduce the nephrotoxicity of amphotericin B,” Surgery Gynecology and Obstetrics, vol. 134, no. 2, pp. 241–243, 1972. View at Google Scholar · View at Scopus
  5. J. M. Rosch, G. J. Pazin, and P. Fireman, “Reduction of amphotericin B nephrotoxicity with mannitol,” Journal of the American Medical Association, vol. 235, no. 18, pp. 1995–1996, 1976. View at Publisher · View at Google Scholar · View at Scopus
  6. J. J. Olivero, J. Lozano-Mendez, E. M. Ghafary, G. Eknoyan, and W. N. Suki, “Mitigation of amphotericin B nephrotoxicity by mannitol,” British Medical Journal, vol. 1, no. 5957, pp. 550–551, 1975. View at Google Scholar · View at Scopus
  7. A. Koyu, F. Ozguner, H. R. Yilmaz, E. Uz, G. Cesur, and N. Ozcelik, “The protective effect of caffeic acid phenethyl ester (CAPE) on oxidative stress in rat liver exposed to the 900 MHz electromagnetic field,” Toxicology and Industrial Health, vol. 25, no. 6, pp. 429–434, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Ilhan, U. Koltuksuz, S. Ozen, E. Uz, H. Ciralik, and O. Akyol, “The effects of caffeic acid phenethyl ester (CAPE) on spinal cord ischemia/reperfusion injury in rabbits,” European Journal of Cardio-thoracic Surgery, vol. 16, no. 4, pp. 458–463, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. C. V. Rao, D. Desai, B. Kaul, S. Amin, and B. S. Reddy, “Effect of caffeic acid esters on carcinogen-induced mutagenicity and human colon adenocarcinoma cell growth,” Chemico-Biological Interactions, vol. 84, no. 3, pp. 277–290, 1992. View at Publisher · View at Google Scholar · View at Scopus
  10. G. F. Sud'ina, O. K. Mirzoeva, M. A. Pushkareva, G. A. Korshunova, N. V. Sumbatyan, and S. D. Varfolomeev, “Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties,” FEBS Letters, vol. 329, no. 1-2, pp. 21–24, 1993. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Michaluart, J. L. Masferrer, A. M. Carothers et al., “Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation,” Cancer Research, vol. 59, no. 10, pp. 2347–2352, 1999. View at Google Scholar · View at Scopus
  12. Y. J. Chen, M. S. Shiao, and S. Y. Wang, “The antioxidant caffeic acid phenethyl ester induces apoptosis associated with selective scavenging of hydrogen peroxide in human leukemic HL-60 cells,” Anti-Cancer Drugs, vol. 12, no. 2, pp. 143–149, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. M. R. Fesen, Y. Pommier, F. Leteurtre, S. Hiroguchi, J. Yung, and K. W. Kohn, “Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds,” Biochemical Pharmacology, vol. 48, no. 3, pp. 595–608, 1994. View at Publisher · View at Google Scholar · View at Scopus
  14. E. H. Park and J. H. Kahng, “Suppressive effects of propolis in rat adjuvant arthritis,” Archives of Pharmacal Research, vol. 22, no. 6, pp. 554–558, 1999. View at Google Scholar · View at Scopus
  15. I. Kus, N. Colakoglu, H. Pekmez, D. Seckin, M. Ogeturk, and M. Sarsilmaz, “Protective effects of caffeic acid phenethyl ester (CAPE) on carbon tetrachloride-induced hepatotoxicity in rats,” Acta Histochemica, vol. 106, no. 4, pp. 289–297, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Ogeturk, I. Kus, N. Colakoglu, I. Zararsiz, N. Ilhan, and M. Sarsilmaz, “Caffeic acid phenethyl ester protects kidneys against carbon tetrachloride toxicity in rats,” Journal of Ethnopharmacology, vol. 97, no. 2, pp. 273–280, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Iraz, E. Ozerol, M. Gulec et al., “Protective effect of caffeic acid phenethyl ester (CAPE) administration on cisplatin-induced oxidative damage to liver in rat,” Cell Biochemistry and Function, vol. 24, no. 4, pp. 357–361, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. H. R. Yilmaz, S. Sogut, B. Ozyurt et al., “The activities of liver adenosine deaminase, xanthine oxidase, catalase, superoxide dismutase enzymes and the levels of malondialdehyde and nitric oxide after cisplatin toxicity in rats: protective effect of caffeic acid phenethyl ester,” Toxicology and Industrial Health, vol. 21, no. 3-4, pp. 67–73, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Feldman, S. Efrati, V. Dishy et al., “N-acetylcysteine ameliorates amphotericin-induced nephropathy in rats,” Nephron—Physiology, vol. 99, no. 1, pp. p23–p27, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. O. H. Lowry, N. J. Rosebrough, and A. L. Farr, “Protein measurement with the Folin phenol reagent,” The Journal of biological chemistry, vol. 193, no. 1, pp. 265–275, 1951. View at Google Scholar · View at Scopus
  21. M. A. Abdel-wahhab, S. A. Nada, and M. S. Arbid, “Ochratoxicosis: prevention of developmental toxicity by L-methionine in rats,” Journal of Applied Toxicology, vol. 19, no. 1, pp. 7–12, 1999. View at Google Scholar
  22. H. H. Draper and M. Hadley, “Malondialdehyde determination as index of lipid peroxidation,” Methods in Enzymology, vol. 186, pp. 421–431, 1990. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Sun, L. W. Oberley, and Y. Li, “A simple method for clinical assay of superoxide dismutase,” Clinical Chemistry, vol. 34, no. 3, pp. 497–500, 1988. View at Google Scholar · View at Scopus
  24. H. Aebi, “Catalase in vitro,” Methods in Enzymology, vol. 105, pp. 121–126, 1984. View at Publisher · View at Google Scholar · View at Scopus
  25. N. K. Cortas and N. W. Wakid, “Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method,” Clinical Chemistry, vol. 36, no. 8, pp. 1440–1443, 1990. View at Google Scholar · View at Scopus
  26. Y. Tonomura, E. Yamamoto, C. Kondo et al., “Amphotericin B-induced nephrotoxicity: characterization of blood and urinary biochemistry and renal morphology in mice,” Human and Experimental Toxicology, vol. 28, no. 5, pp. 293–300, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. Z. Odabasi, A. Karaalp, H. Cermik et al., “Reduction of amphotericin B-induced renal tubular apoptosis by N-acetylcysteine,” Antimicrobial Agents and Chemotherapy, vol. 53, no. 7, pp. 3100–3102, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. M. L. Urso and P. M. Clarkson, “Oxidative stress, exercise, and antioxidant supplementation,” Toxicology, vol. 189, no. 1-2, pp. 41–54, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. H. M. Kim, J. H. Shin, Y. B. Cho, and J. H. Roe, “Inverse regulation of Fe- and Ni-containing SOD genes by a Fur family regulator Nur through small RNA processed from 3′UTR of the sodF mRNA,” Nucleic Acids Res, vol. 42, no. 3, pp. 2003–2014, 2014. View at Google Scholar
  30. H. Pekmez, M. Ogeturk, H. Ozyurt, M. F. Sonmez, N. Colakoglu, and I. Kus, “Ameliorative effect of caffeic acid phenethyl ester on histopathological and biochemical changes induced by cigarette smoke in rat kidney,” Toxicology and Industrial Health, vol. 26, no. 3, pp. 175–182, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. G. Serarslan, E. Altuǧ, T. Kontas, E. Atik, and G. Avci, “Caffeic acid phenetyl ester accelerates cutaneous wound healing in a rat model and decreases oxidative stress,” Clinical and Experimental Dermatology, vol. 32, no. 6, pp. 709–715, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. R. A. Fielding and M. Meydani, “Exercise, free radical generation, and aging,” Aging, vol. 9, no. 1-2, pp. 12–18, 1997. View at Google Scholar · View at Scopus
  33. F. Oktem, F. Ozguner, O. Sulak et al., “Lithium-induced renal toxicity in rats: protection by a novel antioxidant caffeic acid phenethyl ester,” Molecular and Cellular Biochemistry, vol. 277, no. 1-2, pp. 109–115, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Meydan, A. Nacar, O. H. Oztürk et al., “The protective effects of caffeic acid phenethyl ester against toluene-induced nephrotoxicity in rats,” Toxicology and Industrial Health, 2013. View at Publisher · View at Google Scholar
  35. F. O. Aygün, F. Z. Akçam, O. Kaya, B. M. Ceyhan, and R. Sütçü, “Caffeic acid phenethyl ester modulates gentamicin-induced oxidative nephrotoxicity in kidney of rats,” Biological Trace Element Research, vol. 145, no. 2, pp. 211–216, 2012. View at Google Scholar
  36. E. Uz, F. Öktem, H. R. Yilmaz, E. Uzar, and F. Özgüner, “The activities of purine-catabolizing enzymes and the level of nitric oxide in rat kidneys subjected to methotrexate: Protective effect of caffeic acid phenethyl ester,” Molecular and Cellular Biochemistry, vol. 277, no. 1-2, pp. 165–170, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. I. Chirino and J. Pedraza-Chaverri, “Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity,” Experimental and Toxicologic Pathology, vol. 61, no. 3, pp. 223–242, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Kart, Y. Cigremis, M. Karaman, and H. Ozen, “Caffeic acid phenethyl ester (CAPE) ameliorates cisplatin-induced hepatotoxicity in rabbit,” Experimental and Toxicologic Pathology, vol. 62, no. 1, pp. 45–52, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Tekin, T. Küçükkartallar, S. Türkyilmaz et al., “Effects of caffeic acid phenethyl ester (CAPE) on sepsis in rats,” Inflammation, vol. 31, no. 4, pp. 273–280, 2008. View at Google Scholar
  40. F. Öktem, H. R. Yilmaz, F. Ozguner et al., “Methotrexate-induced renal oxidative stress in rats: the role of a novel antioxidant caffeic acid phenethyl ester,” Toxicology and Industrial Health, vol. 22, no. 6, pp. 241–247, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. Z. Ginis, G. Ozturk, A. Albayrak, S. N. Kurt, M. Albayrak, and E. Fadillioglu, “Protective effects of caffeic acid phenethyl ester on ifosfamide-induced central neurotoxicity in rats,” Toxicology and Industrial Health, 2013. View at Publisher · View at Google Scholar